Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposure.

Antimicrobial agents and chemotherapy - 1 Aug 2013

Shields Ryan K, Nguyen M Hong, Press Ellen G, Updike Cassaundra L, Clancy Cornelius J

Abstract excerpt

Mutations in Candida glabrata FKS genes, which encode the echinocandin target enzyme, are independent risk factors for treatment failures during invasive candidiasis. We retrospectively compared the ability of caspofungin susceptibility testing methods to identify C. glabrata FKS mutant isolates...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antifungal Agents
Share to Candida glabrata
Share to Caspofungin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Fungal

Share to Echinocandins

Share to Lipopeptides

Share to Predictive Value of Tests

Share to ROC Curve

Source

Open in PubMed Open full text

Identifiers

PMID: 23669387
DOI: 10.1128/AAC.00136-13
PMCID: PMC3719767

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23669387-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposure.PMID 23669387Read ↗

The presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata.Semantic proximity Read ↗

Clinical perspectives on echinocandin resistance among Candida species.Semantic proximity Read ↗

FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia.Semantic proximity Read ↗

Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.Semantic proximity Read ↗

Optimizing Echinocandin dosing and susceptibility breakpoint determination via in vivo pharmacodynamic evaluation against Candida glabrata with and without fks mutations.Semantic proximity Read ↗

Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance.Semantic proximity Read ↗

Rapid emergence of echinocandin resistance in Candida glabrata resulting in clinical and microbiologic failure.Semantic proximity Read ↗

Assessment of caspofungin susceptibility of Candida glabrata by the Etest®, CLSI, and EUCAST methods, and detection of FKS1 and FKS2 mutations.Semantic proximity Read ↗

Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.Semantic proximity Read ↗

Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates.Semantic proximity Read ↗

Echinocandin Resistance in Candida.Semantic proximity Read ↗

FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based surveillance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.